• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多药耐药菌对肺移植候选患者的影响。

Impact of multidrug-resistant organisms on patients considered for lung transplantation.

机构信息

Transplant and Oncology Infectious Diseases Program, Johns Hopkins University School of Medicine, 1830 Baltimore, MD 21205, USA.

出版信息

Infect Dis Clin North Am. 2013 Jun;27(2):343-58. doi: 10.1016/j.idc.2013.02.006. Epub 2013 Apr 17.

DOI:10.1016/j.idc.2013.02.006
PMID:23714344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4012538/
Abstract

Infections with multidrug-resistant organisms are a growing problem in lung transplant recipients. Carriage of drug-resistant bacteria and fungi before transplantation is an important risk factor for such infections. In that regard Pseudomonas aeruginosa and species of Burkholderia, Acinetobacter, non-tuberculous mycobacteria and Scedosporium are particularly important. An understanding of the impact of these organisms is essential to the evaluation of lung transplant candidates. The microbiology, epidemiology, clinical manifestations, and approach to these pathogens before transplant are reviewed in this article.

摘要

肺移植受者中,多重耐药菌感染是一个日益严重的问题。移植前携带耐药菌和真菌是此类感染的一个重要危险因素。在这方面,铜绿假单胞菌和伯克霍尔德菌属、不动杆菌属、非结核分枝杆菌和枝顶孢属的物种尤其重要。了解这些病原体的影响对于评估肺移植候选者至关重要。本文综述了这些病原体在移植前的微生物学、流行病学、临床表现和处理方法。

相似文献

1
Impact of multidrug-resistant organisms on patients considered for lung transplantation.多药耐药菌对肺移植候选患者的影响。
Infect Dis Clin North Am. 2013 Jun;27(2):343-58. doi: 10.1016/j.idc.2013.02.006. Epub 2013 Apr 17.
2
Multidrug-resistant bacteria in solid organ transplant recipients.实体器官移植受者中的耐多药细菌。
Clin Microbiol Infect. 2014 Sep;20 Suppl 7:49-73. doi: 10.1111/1469-0691.12687.
3
Infections due to multidrug-resistant organisms following heart transplantation: Epidemiology, microbiology, and outcomes.心脏移植后多重耐药菌感染:流行病学、微生物学及预后
Transpl Infect Dis. 2020 Feb;22(1):e13215. doi: 10.1111/tid.13215. Epub 2019 Dec 12.
4
Donor-derived bacterial infections in lung transplant recipients in the era of multidrug resistance.肺移植受者在耐药时代的供体源性细菌感染。
J Infect. 2020 Feb;80(2):190-196. doi: 10.1016/j.jinf.2019.12.006. Epub 2019 Dec 13.
5
Complex bacterial infections pre- and posttransplant.移植前后的复杂细菌性感染。
Semin Respir Crit Care Med. 2010 Apr;31(2):234-42. doi: 10.1055/s-0030-1249119. Epub 2010 Mar 30.
6
Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients.多重耐药肠杆菌科细菌、铜绿假单胞菌和耐万古霉素肠球菌:造血干细胞移植受者面临的三大威胁。
Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12762. Epub 2017 Oct 25.
7
Infection among adult small bowel and multivisceral transplant recipients in the 30-day postoperative period.成人小肠和多脏器移植受者术后30天内的感染情况。
Transpl Infect Dis. 2013 Oct;15(5):441-8. doi: 10.1111/tid.12107. Epub 2013 Jun 28.
8
Early clinical experience of bacteriophage therapy in 3 lung transplant recipients.3 例肺移植受者中噬菌体治疗的早期临床经验。
Am J Transplant. 2019 Sep;19(9):2631-2639. doi: 10.1111/ajt.15503. Epub 2019 Jul 17.
9
The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre.泛耐药细菌病原体对囊性纤维化患者肺移植术后生存的影响:来自单一大型转诊中心的结果
J Hosp Infect. 2004 Apr;56(4):277-82. doi: 10.1016/j.jhin.2004.01.003.
10
Nocardia infection in lung transplant recipients.肺移植受者中的诺卡菌感染。
Clin Transplant. 2008 Sep-Oct;22(5):562-6. doi: 10.1111/j.1399-0012.2008.00824.x. Epub 2008 Apr 23.

引用本文的文献

1
Prevention and Management of Infections in Lung Transplant Recipients.肺移植受者感染的预防与管理
J Clin Med. 2023 Dec 19;13(1):11. doi: 10.3390/jcm13010011.
2
Prognostic impact of preoperative respiratory colonization on early-onset pneumonia after lung transplantation.术前呼吸道定植对肺移植术后早发性肺炎的预后影响
J Thorac Dis. 2022 Jun;14(6):1900-1908. doi: 10.21037/jtd-21-1724.
3
Bacterial infections in lung transplantation.肺移植中的细菌感染
J Thorac Dis. 2021 Nov;13(11):6654-6672. doi: 10.21037/jtd-2021-12.
4
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients.肺移植受者呼吸道细菌定植和感染的发生率及危险因素。
Eur J Clin Microbiol Infect Dis. 2021 Jun;40(6):1271-1282. doi: 10.1007/s10096-021-04153-1. Epub 2021 Jan 21.
5
Developments in lung transplantation over the past decade.过去十年间肺移植的发展。
Eur Respir Rev. 2020 Jul 21;29(157). doi: 10.1183/16000617.0132-2019. Print 2020 Sep 30.
6
Management and prophylaxis of bacterial and mycobacterial infections among lung transplant recipients.肺移植受者中细菌和分枝杆菌感染的管理与预防
Ann Transl Med. 2020 Mar;8(6):413. doi: 10.21037/atm.2020.01.120.
7
Lung Abscess: An Early Complication of Lung Transplantation in a Patient with Cystic Fibrosis.肺脓肿:一名囊性纤维化患者肺移植后的早期并发症
Int J Organ Transplant Med. 2017;8(4):213-216. Epub 2017 Nov 1.
8
AcrB-AcrA Fusion Proteins That Act as Multidrug Efflux Transporters.作为多药外排转运蛋白的AcrB-AcrA融合蛋白。
J Bacteriol. 2015 Nov 2;198(2):332-42. doi: 10.1128/JB.00587-15. Print 2016 Jan 15.

本文引用的文献

1
The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.成人囊性纤维化气道微生物群随时间和感染类型保持稳定,并且对加重期的抗生素治疗具有高度弹性。
PLoS One. 2012;7(9):e45001. doi: 10.1371/journal.pone.0045001. Epub 2012 Sep 26.
2
Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy?囊性纤维化患者中早发伯克霍尔德菌复合感染能否通过抗生素治疗根除?
Front Cell Infect Microbiol. 2011 Dec 21;1:18. doi: 10.3389/fcimb.2011.00018. eCollection 2011.
3
Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry.960 例侵袭性曲霉菌病患者的临床流行病学分析:PATH 联盟注册研究。
J Infect. 2012 Nov;65(5):453-64. doi: 10.1016/j.jinf.2012.08.003. Epub 2012 Aug 13.
4
Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study.肺移植受者中的非结核分枝杆菌感染:一项15年队列研究。
Transpl Infect Dis. 2012 Oct;14(5):452-60. doi: 10.1111/j.1399-3062.2012.00753.x. Epub 2012 Jun 8.
5
Decade-long bacterial community dynamics in cystic fibrosis airways.囊性纤维化气道中长达十年的细菌群落动态。
Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):5809-14. doi: 10.1073/pnas.1120577109. Epub 2012 Mar 26.
6
Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.棘孢木霉属和拟青霉属种的种特异性抗真菌药敏模式。
Antimicrob Agents Chemother. 2012 May;56(5):2635-42. doi: 10.1128/AAC.05910-11. Epub 2012 Jan 30.
7
Scedosporium apiospermum atrial mycetomas after lung transplantation for cystic fibrosis.囊性纤维化患者肺移植后出现的阿氏瓶霉性心房足菌肿
Transpl Infect Dis. 2012 Apr;14(2):188-91. doi: 10.1111/j.1399-3062.2011.00679.x. Epub 2011 Sep 28.
8
Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.2001-2006 年美国移植受者中侵袭性非曲霉属霉菌感染。
Emerg Infect Dis. 2011 Oct;17(10):1855-64. doi: 10.3201/eid1710.110087.
9
Infection and colonisation due to Scedosporium in Northern Spain. An in vitro antifungal susceptibility and molecular epidemiology study of 60 isolates.西班牙北部的枝孢属真菌感染和定植:60 株分离株的体外抗真菌药敏和分子流行病学研究。
Mycoses. 2011 Oct;54 Suppl 3:12-21. doi: 10.1111/j.1439-0507.2011.02110.x.
10
Reverse line blot hybridisation screening of Pseudallescheria/Scedosporium species in patients with cystic fibrosis.囊性纤维化患者中拟青霉/枝孢霉属的反向线杂交筛选。
Mycoses. 2011 Oct;54 Suppl 3:5-11. doi: 10.1111/j.1439-0507.2011.02108.x.